Trial NCT02317419

View at ClinicalTrials.gov 
Org. Study IDs: BP29387
Secondary IDs: 2014-002935-32

Last trial update was posted on 2016-07-26

MeSH Interventions

Gemcitabine LMB-100 Paclitaxel

MeSH Conditions


Other Conditions

Cancer

Stopping Reasons

The study was prematurely terminated because the emerging benefit:risk ratio did not justify continuing dosing patients.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID